206 Results

People

  1. Chung
    Chung
  2. Giralt
    Giralt
  3. Landau
    Landau
  4. Lesokhin
    Lesokhin
  5. Hassoun
    Hassoun
  6. Shah
    Shah
  7. Korde
    Korde
  8. Mailankody
    Mailankody
  9. Scordo
    Scordo
  10. Devlin
    Devlin

Groups

  1. Bone Marrow Transplant (206)
  2. Center for Hematologic Malignancies (206)
  3. Department of Medicine (206)
  4. Hematologic Malignancies, Division of (206)
  5. Survivorship Research (184)
  6. Myeloma (153)
  7. Hematologic Malignancies Research (148)
  8. Epidemiology and Biostatistics (129)
  9. Biostatistics Service (122)
  10. CTCR Scholars (110)
  1. "Hematologic Malignancies, Division of"
  2. "Bone Marrow Transplant"
  3. "David Chung"
Formats
  1. Meeting Abstract (146)
  2. Journal Article (53)
  3. Research Letter (3)
  4. Correspondence (2)
  5. Book Section (1)
  6. Review (1)
Groups
  1. Bone Marrow Transplant (206)
  2. Center for Hematologic Malignancies (206)
  3. Department of Medicine (206)
  4. Hematologic Malignancies, Division of (206)
  5. Survivorship Research (184)
  6. Myeloma (153)

More Groups

People
  1. David Chung (206)
  2. Sergio Giralt (171)
  3. Heather Landau (170)
  4. Alexander Lesokhin (138)
  5. Hani Hassoun (132)
  6. Gunjan Shah (121)

More People

Years
  1. 2024 (1)
  2. 2023 (40)
  3. 2022 (34)
  4. 2021 (15)
  5. 2020 (18)
  6. 2019 (13)

More Years

Publications
  1. Blood (80)
  2. Clinical Lymphoma, Myeloma and Leukemia (33)
  3. Biology of Blood and Marrow Transplantation (28)
  4. Leukemia and Lymphoma (9)
  5. Transplantation and Cellular Therapy (7)
  6. Bone Marrow Transplantation (6)

More Publications

Publishers
  1. American Society of Hematology (82)
  2. Elsevier Inc. (71)
  3. American Association for Cancer Research (9)
  4. Nature Publishing Group (9)
  5. Taylor & Francis Group (9)
  6. American Society of Clinical Oncology (5)

More Publishers

Results (206)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes and management of the SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation and chimeric antigen receptor T cell therapy
    Journal Article

    Infante, M. S.; Nemirovsky, D.; Devlin, S.; DeWolf, S.; Tamari, R.; Dahi, P. B.; Lee, Y. J.; Chung, D. J.; Politikos, I.; Barker, J.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Artificial intelligence enabled ECG interpretation informs outcomes after autologous transplantation for multiple myeloma
    Meeting Abstract

    Shaffer, B. C.; Attia, I. Z.; Greason, G.; Chinapen, S.; Brown, S.; Chung, D.; Lahoud, O. B.; Lopez-Jimenez, F.; Schaffer, W.; Liu, J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) and daratumumab, carfilzomib, lenalidomide and dexamethasone (DKRd) as induction therapy in newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Patel, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • T-cell exhaustion signature predicts early relapse after autologous stem cell transplant for multiple myeloma: BMT CTN 0702 secondary immune analysis
    Meeting Abstract

    Mehanna, N.; Derkach, A.; Gasmi, B.; Anagnostou, T.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Hassoun, H.; Maclachlan, K. H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comprehensive genomic characterization of response and resistance to daratumumab-based quadruplet induction in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K. H.; Tan, C. R.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Nemirovsky, D.; Derkach, A.; McPherson, A.; Diamond, B.; Ziccheddu, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The complex structural variant chromothripsis can be defined on targeted sequencing panels, allowing direct clinical translation in order to improve multiple myeloma prognostication
    Meeting Abstract

    Maclachlan, K. H.; Ziccheddu, B.; Tan, C.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Diamond, B.; Hassoun, H.; Mailankody, S.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Identifying causes of unscheduled healthcare interactions and changes to patient disposition in individuals receiving outpatient commercial bispecific antibody therapy in relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Howard, A. J.; Shekarkhand, T.; Hamadeh, I. S.; Wang, A.; Patel, D.; Tan, C.; Hultcrantz, M.; Mailankody, S.; Hassoun, H.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A whole foods plant-based weight loss intervention improves quality of life, metabolic, microbiome and immune profile in MGUS/SMM as well as progression trajectory in a subset - the Nutrivention trial
    Meeting Abstract

    Shah, U. A.; Castro, F.; Derkach, A.; Fei, T.; Hosszu, K. K.; McAvoy, D.; DeWolf, S.; Cross, J.; Gradissimo, A.; Nwankwo, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Carfilzomib,lenalidomide and dexamethasone (KRd) as induction therapy in high-risk newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C.; Korde, N.; Derkach, A.; Hultcrantz, M.; Maclachlan, K. H.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Patel, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Meeting Abstract

    Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
    Blood (2023)

    Fulltext@MSK | Save